Up-regulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection.

[1]  G. Splitter,et al.  Interleukin-12 p40 mRNA Expression in Bovine Leukemia Virus-Infected Animals: Increase in Alymphocytosis but Decrease in Persistent Lymphocytosis , 1998, Journal of Virology.

[2]  H. Bluethmann,et al.  Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. , 1998, Journal of immunology.

[3]  S. Frøland,et al.  Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load. , 1997, Blood.

[4]  S. Tajima,et al.  Point mutation of p53 tumor suppressor gene in bovine leukemia virus-induced lymphosarcoma. , 1997, Leukemia.

[5]  K. Ohashi,et al.  An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep. , 1996, Vaccine.

[6]  M. Onuma,et al.  Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome. , 1996, Vaccine.

[7]  G. Splitter,et al.  Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus , 1996, Journal of virology.

[8]  N. Day,et al.  Immunosuppressive retroviral peptides: cAMP and cytokine patterns. , 1995, Immunology today.

[9]  J. Covert,et al.  Detection of cytokine transcriptional profiles from bovine peripheral blood mononuclear cells and CD4+ lymphocytes by reverse transcriptase polymerase chain reaction. , 1995, Veterinary immunology and immunopathology.

[10]  W. Langhans,et al.  Effect of bovine leukemia virus infection on bovine peripheral blood monocyte responsiveness to lipopolysaccharide stimulation in vitro. , 1995, Veterinary immunology and immunopathology.

[11]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[12]  Y. Ikawa,et al.  Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses. , 1994, Therapeutic immunology.

[13]  N. Liabakk,et al.  Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .

[14]  A. Burny,et al.  Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51 , 1993, Journal of virology.

[15]  A. Ramsay,et al.  A case for cytokines as effector molecules in the resolution of virus infection. , 1993, Immunology today.

[16]  Hassan Mohammad Naif,et al.  Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70 , 1993, Journal of virology.

[17]  M. Gatei,et al.  T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development , 1993, Journal of virology.

[18]  F. Pociot,et al.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles , 1993, The Journal of experimental medicine.

[19]  T. Folks,et al.  Regulation of HIV-1 expression by cytokine networks in a CD4+ model of chronic infection. , 1993, Journal of immunology.

[20]  J. Letesson,et al.  CD5+ B cells from bovine leukemia virus infected cows are activated cycling cells responsive to interleukin 2. , 1992, Leukemia.

[21]  C. Jacob,et al.  Polymorphisms in the tumor necrosis factor alpha (TNF-alpha) gene correlate with murine resistance to development of toxoplasmic encephalitis and with levels of TNF-alpha mRNA in infected brain tissue , 1992, Journal of Experimental Medicine.

[22]  J. Sypek,et al.  Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane , 1991, The Journal of experimental medicine.

[23]  Y. Ikawa,et al.  Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity. , 1991, The Journal of general virology.

[24]  B. Beutler,et al.  Interactive effects of the tumor necrosis factor promoter and 3'-untranslated regions. , 1991, Journal of immunology.

[25]  Jiahuai Han,et al.  Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2] , 1990, The Journal of experimental medicine.

[26]  K. Bendtzen.  Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. , 1988, Immunology letters.

[27]  D. Kufe,et al.  Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. , 1988, The Journal of clinical investigation.

[28]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[29]  I. Schwartz,et al.  Pathobiology of bovine leukemia virus. , 1994, Veterinary research.